SecSonar.com

Sera Prognostics, Inc. (SERA)

Sera Prognostics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sera Prognostics, Inc. (SERA) is a Medical - Diagnostics & Research company based in US with a market capitalization of $85.5M. Revenue grew 5.2% year-over-year and free cash flow was negative at -$26.3M. This page tracks SERA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 63 employees · IPO Jul 15, 2021

Valuation

Valuation & price

$1.72 · as of May 17, 2026 · -54.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.74$2.71$1.69Jul 25Dec 25Jul 26Jul 7, 25$2.42Jul 9, 25$2.66Jul 11, 25$2.84Jul 15, 25$2.70Jul 17, 25$3.00Jul 21, 25$2.92Jul 23, 25$3.11Jul 25, 25$3.25Jul 29, 25$2.90Jul 31, 25$2.78Aug 4, 25$2.59Aug 6, 25$2.75Aug 11, 25$2.34Aug 13, 25$2.30Aug 15, 25$2.25Aug 19, 25$2.25Aug 21, 25$2.38Aug 25, 25$2.64Aug 27, 25$2.84Aug 29, 25$3.23Sep 3, 25$3.40Sep 5, 25$3.34Sep 9, 25$3.10Sep 11, 25$3.07Sep 16, 25$3.08Sep 18, 25$3.20Sep 22, 25$3.28Sep 24, 25$3.09Sep 26, 25$3.09Sep 30, 25$3.06Oct 2, 25$3.13Oct 6, 25$3.26Oct 8, 25$3.15Oct 10, 25$3.06Oct 14, 25$3.15Oct 16, 25$3.34Oct 21, 25$3.36Oct 23, 25$3.35Oct 27, 25$3.74Oct 29, 25$3.49Oct 31, 25$3.28Nov 4, 25$3.02Nov 6, 25$2.70Nov 10, 25$2.55Nov 12, 25$3.12Nov 14, 25$2.96Nov 18, 25$3.12Nov 20, 25$3.13Nov 25, 25$3.40Nov 28, 25$3.33Dec 2, 25$2.90Dec 4, 25$2.98Dec 8, 25$3.05Dec 10, 25$3.40Dec 12, 25$3.51Dec 16, 25$3.56Dec 18, 25$3.57Dec 22, 25$3.60Dec 24, 25$3.60Dec 29, 25$3.27Jan 2, 26$3.00Jan 6, 26$2.96Jan 8, 26$3.53Jan 12, 26$3.60Jan 14, 26$3.54Jan 16, 26$3.66Jan 21, 26$3.55Jan 23, 26$3.24Jan 27, 26$3.00Jan 29, 26$2.80Feb 2, 26$2.78Feb 4, 26$2.63Feb 9, 26$2.68Feb 11, 26$2.59Feb 13, 26$2.65Feb 18, 26$2.59Feb 20, 26$2.51Feb 24, 26$2.25Feb 26, 26$2.29Mar 2, 26$2.23Mar 4, 26$2.02Mar 6, 26$1.95Mar 10, 26$1.83Mar 12, 26$1.99Mar 17, 26$2.01Mar 19, 26$1.79Mar 23, 26$1.82Mar 25, 26$1.99Mar 27, 26$1.85Mar 31, 26$2.03Apr 2, 26$2.01Apr 7, 26$2.16Apr 9, 26$2.09Apr 13, 26$2.13Apr 15, 26$2.18Apr 17, 26$2.30Apr 22, 26$2.14Apr 24, 26$2.01Apr 28, 26$1.98Apr 30, 26$1.94May 4, 26$1.90May 6, 26$1.81May 8, 26$1.88May 12, 26$1.69May 14, 26$1.79May 18, 26$1.75May 20, 26$1.76May 22, 26$2.07May 28, 26$2.14Jun 1, 26$2.19Jun 3, 26$2.05Jun 5, 26$2.29Jun 9, 26$2.13Jun 11, 26$1.93Jun 15, 26$1.84Jun 17, 26$1.89Jun 22, 26$1.85Jun 24, 26$1.80Jun 26, 26$1.80Jul 2, 26$2.00
$1.5952-week range$3.75
Loading valuation history…

Fundamentals

Key fundamentals

$85.5M

Market cap

5.2%

Revenue growth (YoY)

-102.5%

Gross margin

-$26.3M

Free cash flow (USD)

-$36.9M

Net debt

Net cash position

43.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$36.0KFY 2020$25.0KFY 2021$82.0KFY 2022$268.0KFY 2023$306.0KFY 2024$77.0KFY 2025$81.0K
$36K$81K

Free cash flow by year

2019 → 2025

FY 2019$-19.4MFY 2020$-17.0MFY 2021$-32.9MFY 2022$-35.4MFY 2023$-27.3MFY 2024$-15.3MFY 2025$-26.3M
-$19.4M-$26.3M

Gross margin by year

2021 → 2025

FY 202154.9%FY 202228.0%FY 202331.4%FY 2024-6.5%FY 2025-102.5%
54.9%-102.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

8

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector AppointmentJun 30, 2026Filing
  • Insider sellInsider Sell $4KJackson Benjamin · General Counsel · $4.4KJun 15, 2026Filing
  • Insider sellInsider Sell $728Inglis Tiffany Eul Davis · Chief Medical Officer · $727.6Jun 15, 2026Filing
  • Insider sellInsider Sell $14KLindgardt Zhenya · Director, Chief Executive Officer · $14KJun 15, 2026Filing
  • Insider sellInsider Sell $4KAerts Austin · Chief Financial Officer · $4.1KJun 15, 2026Filing
  • Insider sellInsider Sell $10KAnderson Dyaarl Lee Jr. · Chief Commercial Officer · $9.5KJun 15, 2026Filing
  • Insider sellInsider Sell $11KAerts Austin · Chief Financial Officer · $11.3KJun 10, 2026Filing
  • Insider sellInsider Sell $43KLindgardt Zhenya · Director, Chief Executive Officer · $43.2KJun 10, 2026Filing
  • Insider sellInsider Sell $3K · 10b5-1 PlanLawrence Sandra AJ · Director · $3.4KJun 9, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 4, 2026Filing

Questions

Frequently asked questions

What is Sera Prognostics, Inc.'s market cap?

Sera Prognostics, Inc. (SERA) has a market capitalization of $85.5M.

What is SERA's P/E ratio?

A meaningful P/E ratio is not available for SERA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SERA's price-to-book (P/B) ratio?

SERA trades at 1.13 times book value per share.

Are insiders buying SERA stock?

SEC Form 4 filings show no open-market insider buys at Sera Prognostics, Inc. in the last 90 days (8 sells).

Same arena

Related companies in Medical - Diagnostics & Research

STIM

Neuronetics, Inc.

$104.4M

DRIO

DarioHealth Corp.

$55.2M

XGN

Exagen Inc.

$119.6M

ATLN

Atlantic International Corp.

$122.2M

STRR

Star Equity Holdings, Inc.

$42.6M

PRPO

Precipio, Inc.

$41.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.